Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
Kent E. Kester(Walter Reed Army Institute of Research)
Cited by 537
Related Papers
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial
|The Lancet|2001|528
A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease
|Nature Medicine|2004|266
Guidelines for the Prevention of Infections Associated With Combat-Related Injuries: 2011 Update
|The Journal of Trauma: Injury, Infection, and Critical Care|2011|133